TUESDAY, JANUARY 8, 2018 - 8:00AM TO 9:00AM

Vignette:

"Thrombosis in von Willebrand's Disease: the Good, the Bad, and the Ugly"

Ammon Fager, MD, PhD

Assistant Professor of Medicine, Duke Division of Hematology

Feature Talk:

"DOAC use in Obese Patients"

Ashley Hanlon, MD

Heme-Onc Fellow, Duke Division of Hematology

LOCATION: Duke Medicine Pavilion, 10 Duke Medicine Circle, DMP 2W96, Durham, NC 27710

See map: Google Maps

ROOM NUMBER: 

DMP 2W96

_{CME Offered}

The following speakers and/or planning committee members have indicated that they have relationship(s) with industry to disclose:

Ammon Fager, MD, PhD

_{Activity Medical Director/Planning Committee Disclosure(s): The following speakers an d/or planning committee members have indicated they have no relationship(s) with industry to disclose relative to the content of this CME activity:}

Ashley Hanlon, MD

_{JA ACCREDITATION STATEMENT:}

<sub>SUPPORT OF IMPROVING PATIENT CARE, THE DUKE UNIVERSITY HEALTH SYS TEM DEPARTMENT OF CLINICAL EDUCATION & PROFESSIONAL DEVELOPMENT IS ACCREDITED BY THE AMERICAN NURSES CREDENTIALING CENTER (ANCC), THE ACCREDITATION COUNCIL FOR PHARMACY EDUCATION (ACPE), AND THE ACCREDITATION COUNCIL FOR CONTINUING MEDICAL EDUCATION (ACCME), TO PROVIDE CONTINUING EDUCATION FOR THE HEALTH CARE TEAM.

CREDIT DESIGNATION: DUKE UNIVERSITY HEALTH SYSTEM DEPARTMENT OF CLICAL EDUCATION AND PROFESSIONAL DEVELOPME NT DESIGNATES THIS EDUCATIONAL ACTIVITY FOR A MAXIMUM OF 1.0 AMA PRA CATEGORY 1 CREDIT(S)</sub>^TM<sub>. PHYSICIANS SHOULD CLAIM ONLY CREDIT COMMENSURATE WITH THE EXTENT OF THEIR PARTICIPATION THE ACTIVITY.

UNAPPROVED USE DISCLOSURE: DUKE UNIVERSITY HEALTH SYSTEM DEPARTMENT OF CLICAL EDUCATION & PROFESSIONAL DEVELOPMENT REQUIRES FACULTY (SPEAKERS) TO DISCLOSE TO THE ATTENDEES: 1) WHEN PRODUCTS OR PROCEDURES BEING DISCUSSED ARE OFF-LABEL, UNLABELED, EXPERIMENTAL, AND/OR INVESTIGATIONAL (NOT FDA APPROVED) ; AND 2) ANY LIMITATIONS ON THE INFORMATION THAT IS PRESENTED, SUCH AS DATA THAT ARE PRELIMINARY OR THAT REPRESENT ONGOING RESEARCH, INTERIM ANALYSES, AND/OR UNSUPPORTED OPINION. FACULTY AT THIS SYMPOSIUM MAY DISCUSS INFORMATION ABOUT PHARMACEUTICAL AGENTS THAT IS OUTSIDE OF U.S. FOOD AND DRUG ADMINISTRATION APPROVED LABELING. THIS INFORMATION IS INTENDED SOLELY FOR CONTINUIN G MEDICAL EDUCATION AND IS NOT INTENDED TO PROMOTE OFF-LABEL USE OF THESE MEDICATIONS. IF YOU HAVE QUESTIONS, CONTACT THE MEDICAL AFFAIRS DEPARTMENT OF THE MANUFACTURER FOR THE MOST RECENT PRESCRIBING
FORMATION.</sub>